Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

ESC Heart Failure, 2019

Prolargin and matrix metalloproteinase‐2 in heart failure after heart transplantation and their association with haemodynamics

Ahmed A., Ahmed S., Arvidsson M. et al.

BMJ Open Diabetes Research & Care, 2019

Deficiency of T cell CD40L has minor beneficial effects on obesity-induced metabolic dysfunction

Reiche M., den Toom M., Willemsen L. et al.

Annals of Clinical and Translational Neurology, 2019

Transmembrane protease serine 5: a novel Schwann cell plasma marker for CMT1A

Wang H., Davison M., Wang K. et al.

Nutrients, 2019

Exploring the Benefit of 2-Methylbutyric Acid in Patients Undergoing Hemodialysis Using a Cardiovascular Proteomics Approach

Wu P., Chiu Y., Zou H. et al.

Obesity, 2019

Changes in Proteomic Profiles are Related to Changes in BMI and Fat Distribution During 10 Years of Aging

Lind L., Figarska S., Sundström J. et al.

Heliyon, 2019

Multi-biomarker panel signature as the key to diagnosis of ovarian cancer

Muinao T., Deka Boruah H., Pal M.

European Journal of Heart Failure, 2019

The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach

Hoes M., Tromp J., Ouwerkerk W. et al.

Molecular Psychiatry, 2019

An epigenetic predictor of death captures multi-modal measures of brain health

Hillary R., Stevenson A., Cox S. et al.

Nephrology Dialysis Transplantation, 2019

Vascular endothelial growth factor D is a biomarker of fluid overload in haemodialysis patients

von Moos S., Segerer S., Davenport A. et al.

EP Europace, 2019

Atrial fibrillation progression risk factors and associated cardiovascular outcome in well-phenotyped patients: data from the AF-RISK study

De With R., Marcos E., Dudink E. et al.

Clinical Research in Cardiology, 2019

Bioprofiles and mechanistic pathways associated with Cheyne-Stokes respiration: insights from the SERVE-HF trial

Ferreira J., Duarte K., Woehrle H. et al.

Journal for ImmunoTherapy of Cancer, 2019

Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery

Taylor M., Hughes A., Walton J. et al.

Pulmonary Circulation, 2019

Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension

Arvidsson M., Ahmed A., Bouzina H. et al.

Pulmonary Circulation, 2019

Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension

Bouzina H., Hesselstrand R., Rådegran G.

Journal for ImmunoTherapy of Cancer, 2019

Peripheral immune-based biomarkers in cancer immunotherapy: can we realize their predictive potential?

Nixon A., Schalper K., Jacobs I. et al.

Science Signaling, 2019

The human secretome

Uhlén M., Karlsson M., Hober A. et al.

BMJ Open Diabetes Research & Care, 2019

Deficits in systemic biomarkers of neuroinflammation and growth factors promoting nerve regeneration in patients with type 2 diabetes and polyneuropathy

Ziegler D, Strom A, Bönhof GJ et al.

Leukemia, 2019

Interaction kinetics with transcriptomic and secretory responses of CD19-CAR natural killer-cell therapy in CD20 resistant non-hodgkin lymphoma

Ravi D., Sarkar S., Purvey S. et al.

The American Journal of Cardiology, 2019

Usefulness of Certain Protein Biomarkers for Prediction of Coronary Heart Disease

Ong K., Chung R., Hui N. et al.

Clinical Proteomics, 2019

The associations of self-rated health with cardiovascular risk proteins: a proteomics approach

Bao X., Borné Y., Yin S. et al.

4586 publications